These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15310791)

  • 1. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia.
    Creutzig U; Kaspers GJ
    J Clin Oncol; 2004 Aug; 22(16):3432-3. PubMed ID: 15310791
    [No Abstract]   [Full Text] [Related]  

  • 2. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
    Cheson BD; Bennett JM; Kopecky KJ; Büchner T; Willman CL; Estey EH; Schiffer CA; Doehner H; Tallman MS; Lister TA; Lo-Coco F; Willemze R; Biondi A; Hiddemann W; Larson RA; Löwenberg B; Sanz MA; Head DR; Ohno R; Bloomfield CD;
    J Clin Oncol; 2003 Dec; 21(24):4642-9. PubMed ID: 14673054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the revised response criteria for acute myelogenous leukemia.
    Cheson BD
    Clin Adv Hematol Oncol; 2004 May; 2(5):277-9. PubMed ID: 16163193
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Antuono P; Doody R; Gilman S; Huff J; Scheltens P; Ueda K; Khachaturian ZS
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():22-5. PubMed ID: 9305510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodologic issues in investigation of targeted therapies in acute myeloid leukemia.
    Estey E
    Adv Pharmacol; 2004; 51():99-106. PubMed ID: 15464906
    [No Abstract]   [Full Text] [Related]  

  • 6. Response assessments in low-risk and high-risk myelodysplastic syndromes (MDS).
    Fenaux P
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S11-5. PubMed ID: 16085012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Harmonization Project for response criteria in lymphoma clinical trials.
    Cheson BD
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):841-54. PubMed ID: 17908623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
    Abrey LE; Batchelor TT; Ferreri AJ; Gospodarowicz M; Pulczynski EJ; Zucca E; Smith JR; Korfel A; Soussain C; DeAngelis LM; Neuwelt EA; O'Neill BP; Thiel E; Shenkier T; Graus F; van den Bent M; Seymour JF; Poortmans P; Armitage JO; Cavalli F;
    J Clin Oncol; 2005 Aug; 23(22):5034-43. PubMed ID: 15955902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parameters for predicting allogeneic PBSCT outcome of acute myeloid leukemia: cytogenetics at presentation versus disease status at transplantation.
    Kim DH; Sohn SK; Kim JG; Lee NY; Sung WJ; Baek JH; Suh JS; Lee KS; Lee KB
    Ann Hematol; 2005 Jan; 84(1):25-32. PubMed ID: 15349754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
    Valent P; Akin C; Escribano L; Födinger M; Hartmann K; Brockow K; Castells M; Sperr WR; Kluin-Nelemans HC; Hamdy NA; Lortholary O; Robyn J; van Doormaal J; Sotlar K; Hauswirth AW; Arock M; Hermine O; Hellmann A; Triggiani M; Niedoszytko M; Schwartz LB; Orfao A; Horny HP; Metcalfe DD
    Eur J Clin Invest; 2007 Jun; 37(6):435-53. PubMed ID: 17537151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies.
    Oddis CV; Rider LG; Reed AM; Ruperto N; Brunner HI; Koneru B; Feldman BM; Giannini EH; Miller FW;
    Arthritis Rheum; 2005 Sep; 52(9):2607-15. PubMed ID: 16142757
    [No Abstract]   [Full Text] [Related]  

  • 12. Selection of response criteria for clinical trials of sarcoma treatment.
    Schuetze SM; Baker LH; Benjamin RS; Canetta R
    Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of vaccination therapy for leukemias.
    Reichardt VL; Brossart P
    Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.
    Sidiropoulos PI; Hatemi G; Song IH; Avouac J; Collantes E; Hamuryudan V; Herold M; Kvien TK; Mielants H; Mendoza JM; Olivieri I; Østergaard M; Schachna L; Sieper J; Boumpas DT; Dougados M
    Rheumatology (Oxford); 2008 Mar; 47(3):355-61. PubMed ID: 18276738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
    Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standards of proof, standards of practice, and proof of standards: a tale of two trials.
    Browman GP
    J Clin Oncol; 2005 Apr; 23(12):2583-5. PubMed ID: 15710950
    [No Abstract]   [Full Text] [Related]  

  • 19. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
    Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
    Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
    van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
    Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.